STAA
HOLD / NEUTRALNeutralComposite
40.60
Technical
24.40
Fundamental
51.40
Rank
—
Price
24.66
Hurst
0.54
As of
Aug 20, 2026
Daily
STAAR Surgical Company
HealthcareMedical Instruments & SuppliesSTAAR Surgical Company designs and manufactures implantable lens products used in refractive eye surgery to correct vision problems including myopia, hyperopia, astigmatism, and presbyopia. The company markets its lens systems and delivery equipment to ophthalmologists, surgical centers, and hospitals through direct sales teams in major markets and independent distributors globally. Founded in 1982 and based in California, the company serves the ophthalmic medical device sector.
Market cap
$1.2B
P/E (trailing)
306.75
P/E (forward)
22.08
PEG ratio
0.76
Dividend yield
0.00%
Beta
1.18
52w range
15.59 – 35.87
Return on equity
+1.09%
Profit margin
+1.13%
Revenue growth
+111.00%
Earnings growth
—
Price history
1Y: 24.54 (-5.1%) · range 16.10–33.34
Cycle position
50/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 18 · NOT READY · exit proximity 0
Conviction
24/ 100 · maturity 0%
Buildup.3312
EMA entry setup.4218
Fundamentals.2551
Volume profile
POC
22.58
Price vs POC
+8.7%
Overhead supply
47%
Runway
open sky
Value area 19.72–28.13 · 47% of 120d volume overhead · moderate overhead
Contributing sources
No source detections in the last 21 days.
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -8.40% | +7.91% | mature |
| 40d | +0.98% | +7.91% | mature |